Takimoto, Chris H.
Janssen Research & Development,
United States
2024 Rank: 71698
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2949 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71698 | 80613 |
| Total Cites | 8201 | 8768 |
| H-index | 43 | 44 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 280 | 283 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1597 | 1682 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 2100 | 2236 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7612 | 8067 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
6.47%
|
|
Takimoto, Chris H.
Janssen Research & Development,
United States
2023 Rank: 66839
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2797 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66839 | 76000 |
| Total Cites | 8001 | 8566 |
| H-index | 43 | 43 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 274 | 277 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1556 | 1641 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 2040 | 2176 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7423 | 7876 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
6.60%
|
|
Takimoto, Chris H.
Janssen Research & Development,
United States
2022 Rank: 65129
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2740 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65129 | 73758 |
| Total Cites | 7425 | 7974 |
| H-index | 41 | 42 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 253 | 256 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1499 | 1584 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 1927 | 2063 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6887 | 7324 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
6.88%
|
|
Takimoto, Chris H.
Janssen Research & Development,
United States
2021 Rank: 64054
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2701 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64054 | 71861 |
| Total Cites | 7251 | 7788 |
| H-index | 41 | 41 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 243 | 246 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1454 | 1535 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 1866 | 1998 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6722 | 7149 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
6.90%
|
|
Takimoto, Chris H.
Janssen Research & Development,
United States
2020 Rank: 57374
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2552 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57374 | 64851 |
| Total Cites | 7266 | 7811 |
| H-index | 41 | 42 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 225 | 228 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 1402 | 1484 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 1830 | 1962 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6718 | 7152 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
6.98%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.